SEOUL, March 31 (Korea Bizwire) — South Korean pharmaceutical and biotech companies that surpassed 1 trillion won in annual revenue showed stark differences in operating efficiency, with employee productivity varying by as much as 19 times among industry leaders. According to industry data released March 30, nine companies joined the “trillion-won club” in 2024: Samsung Biologics, [...]
SEOUL, March 20 (Korea Bizwire) – Pharmaceutical and biotech companies in South Korea are intensifying their efforts to diversify business operations, seeking to improve profitability and strengthen competitiveness by securing future growth engines. According to industry sources, ENCell, a company specializing in new drug development, plans to add artificial intelligence software development and services to its [...]
SEOUL, Feb. 27 (Korea Bizwire) — South Korean pharmaceutical and biotech companies are rapidly expanding their presence in the Middle Eastern market, capitalizing on the region’s growing healthcare demands and high-income population. Daewoong Pharmaceutical recently launched its botulinum toxin product, Nabota, in Saudi Arabia, a market known for its stringent entry barriers for such products. The company [...]
SEOUL, Feb. 20 (Korea Bizwire) — South Korean pharmaceutical and biotech companies are scrambling to prepare for potential new tariffs threatened by American President Donald Trump on foreign-made drugs entering the U.S. market. Celltrion, a major South Korean biopharmaceutical company, announced on its website on February 19 that it has established an “optimal response system” to [...]
SEOUL, Feb. 19 (Korea Bizwire) — South Korea’s pharmaceutical and biotech sector has kicked off 2024 with a flurry of merger and acquisition activity, as companies move to strengthen their market positions and diversify their portfolios. GC Wellbeing, a subsidiary of GC Group, recently acquired Inibio, a developer of botox products, in a move to expand [...]
SEOUL, Jan. 30 (Korea Bizwire) — South Korean drug manufacturers are rapidly expanding their presence in the global autoimmune disease treatment market, challenging the longtime dominance of Western pharmaceutical giants. Autoimmune diseases, which occur when the body’s immune system mistakenly attacks its own organs, tissues, and cells, encompass a range of conditions including rheumatoid arthritis, multiple sclerosis, [...]
SEOUL, Sept. 30 (Korea Bizwire) – In the pharmaceutical industry, glass bottles continue to play a significant role in packaging both over-the-counter and prescription medications, despite ongoing challenges with breakage and contamination risks. While glass containers are prized for their ability to preserve drug integrity, their fragility has prompted pharmaceutical companies to seek alternative solutions, including [...]
SEOUL, Jul. 25 (Korea Bizwire) – As South Korea grapples with its alarmingly low birth rate, the pharmaceutical and biotech industries are joining the effort to address this pressing social issue. Companies are expanding childbirth subsidies and implementing support measures for couples struggling with infertility, all in a bid to encourage employees to have children. According [...]
SEOUL, Jun. 6 (Korea Bizwire) –Domestic pharmaceutical firms in South Korea are increasingly joining forces with former competitors to develop new drugs, marking a shift in strategy. While co-marketing existing products or outsourcing manufacturing has been common practice, collaborations now extend to the realm of novel drug development. Last month, Ildong Pharmaceutical secured Dong-A Socio [...]
SEOUL, Jun. 4 (Korea Bizwire) – Pharmaceutical and biotechnology companies at home and abroad are striving to recreate the value of their products by expanding the therapeutic areas they can be used for, known as new indications. In March, the U.S. Food and Drug Administration approved the obesity drug Wegovy, made by the Danish company Novo [...]